Detalhe da pesquisa
1.
Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetes.
Bioorg Med Chem
; 35: 116071, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33611013
2.
Anticancer, antimicrobial activities of quinoline based hydrazone analogues: Synthesis, characterization and molecular docking.
Bioorg Chem
; 94: 103406, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31718889
3.
Design, synthesis and biological evaluation of novel aminomethyl-piperidones based DPP-IV inhibitors.
Bioorg Med Chem Lett
; 24(8): 1918-22, 2014 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24675378
4.
In the Quest for Potent and Selective Malic Enzyme 3 Inhibitors for the Treatment of Pancreatic Ductal Adenocarcinoma.
ACS Med Chem Lett
; 14(1): 41-50, 2023 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36655126
5.
Long-acting peptidomimetics based DPP-IV inhibitors.
Bioorg Med Chem Lett
; 22(10): 3516-21, 2012 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22503246
6.
Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors.
Bioorg Med Chem Lett
; 22(2): 1111-7, 2012 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22189136
7.
Modulation of PPAR subtype selectivity. Part 2: Transforming PPARα/γ dual agonist into α selective PPAR agonist through bioisosteric modification.
Bioorg Med Chem Lett
; 21(2): 628-32, 2011 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21195611
8.
Effect of structurally constrained oxime-ether linker on PPAR subtype selectivity: Discovery of a novel and potent series of PPAR-pan agonists.
Bioorg Med Chem
; 19(2): 771-82, 2011 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21215640
9.
Peptidomimetics as potent and selective PTP1B inhibitors.
Med Chem
; 9(5): 660-71, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23030658
10.
Discovery of orally active, potent, and selective benzotriazole-based PTP1B inhibitors.
ChemMedChem
; 6(6): 1011-6, 2011 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-21506278